American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Natera, Inc. Common Stock

NTRA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

NTRA historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of NTRA by members of U.S. Congress

Politician Type Traded
Josh Gottheimer House / D Purchase $1,001 - $15,000 Sep 22, 2025
Josh Gottheimer House / D Purchase $1,001 - $15,000 Aug 22, 2025
Josh Gottheimer House / D Sale $1,001 - $15,000 Jul 22, 2025
Josh Gottheimer House / D Purchase $1,001 - $15,000 Nov 20, 2024
Daniel S. Goldman House / D Sale $1,001 - $15,000 Apr 10, 2023
Daniel S. Goldman House / D Purchase $1,001 - $15,000 Mar 06, 2023
Bill Hagerty Senate / R Sale (Partial) $1,001 - $15,000 Apr 20, 2021
NTRA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NTRA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NTRA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in NTRA holdings by institutional investors

Insider Trading

Quarterly net insider trading by NTRA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $150,000 Jul 10, 2026 Issue: Health Issues
  • $150,000 Apr 14, 2026 Issue: Health Issues
  • $150,000 Jan 12, 2026 Issue: Health Issues
  • $150,000 Oct 15, 2025 Issue: Health Issues
  • $140,000 Jul 18, 2025 Issue: Health Issues
  • $140,000 Apr 15, 2025 Issue: Health Issues
  • $39,000 Jan 15, 2025 Issue: Health Issues Medicare/Medicaid
  • $39,000 Oct 17, 2024 Issue: Medicare/Medicaid Health Issues
  • $39,000 Jul 18, 2024 Issue: Medicare/Medicaid Health Issues
  • $26,000 Jan 23, 2024 Issue: Medicare/Medicaid Health Issues
  • $19,500 Oct 16, 2023 Issue: Medicare/Medicaid Health Issues
  • $19,500 Jul 18, 2023 Issue: Medicare/Medicaid Health Issues
  • $19,500 Jan 26, 2023 Issue: Medicare/Medicaid Health Issues
  • $10,000 Jan 20, 2023 Issue: Health Issues
  • $29,500 Oct 17, 2022 Issue: Medicare/Medicaid Health Issues
  • $34,500 Jul 12, 2022 Issue: Medicare/Medicaid Health Issues
  • $60,000 Apr 19, 2022 Issue: Health Issues
  • $34,500 Apr 11, 2022 Issue: Medicare/Medicaid Health Issues
  • $34,500 Jan 04, 2022 Issue: Medicare/Medicaid Health Issues
  • $34,500 Sep 30, 2021 Issue: Medicare/Medicaid Health Issues
  • $34,500 Aug 17, 2021 Issue: Medicare/Medicaid Health Issues
  • $19,500 Feb 27, 2021 Issue: Medicare/Medicaid Health Issues
  • $19,500 Jan 14, 2021 Issue: Health Issues
  • $19,500 Oct 06, 2020 Issue: Health Issues
  • $19,500 Jul 16, 2020 Issue: Health Issues
  • $19,500 Jul 06, 2020 Issue: Health Issues
  • $19,500 Feb 07, 2020 Issue: Health Issues
  • $6,500 Jul 25, 2019 Issue: Health Issues
  • $6,500 Jun 28, 2019 Issue: Health Issues
  • $6,500 Jun 28, 2019 Issue: Health Issues
  • $10,000 Oct 16, 2018 Issue: Health Issues
  • $10,000 Jul 19, 2018 Issue: Health Issues
  • $10,000 Jan 18, 2018 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid
  • $10,000 Oct 12, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $10,000 Apr 17, 2017 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $30,000 Jan 05, 2017 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Oct 11, 2016 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid
  • $10,000 Jul 15, 2016 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Jan 21, 2016 Issue: None
  • $20,000 Oct 15, 2015 Issue: Health Issues
Revolving Door

Former government officials who have lobbied for NTRA

8 former government officials from 4 congressional offices at 4 lobbying firms have lobbied for NTRA, most recently Jul 05, 2026.

  • Martha Roby
    Sophie Khanahmadi House Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions Formerly with Martha Roby · LMH STRATEGIC SOLUTIONS · Jul 05, 2026
  • Jon C. Porter
    Alanna Temme House Legislative Director, U.S. Representative Jon Porter Formerly with Jon C. Porter · LMH STRATEGIC SOLUTIONS · Jul 05, 2026
  • Reed Craddock House New Rep. Trent Kelly- Deputy Chief of Staff 2020 - 2025, Scheduler, 2018 - 2020, Staff Assistant, 2018 Formerly Trent Kelly- Deputy Chief · ERVIN GRAVES STRATEGY GROUP, LLC · Apr 17, 2026
  • Rod Blum
    Brandon Kirby House New U.S. Representative Rod Blum (R-IA-01), Intern, Staff Assistant/Legislative Correspondent, Legislative Assistant, January 2017 - January 2019 Formerly with Rod Blum · ERVIN GRAVES STRATEGY GROUP, LLC · Mar 31, 2026
  • Benjamin L. Cardin
    Margaret Linehan Senate New U.S. Senator Ben Cardin (D-MD), Foreign Policy Intern, June 2022 - August 2022 Formerly with Benjamin L. Cardin · ERVIN GRAVES STRATEGY GROUP, LLC · Mar 31, 2026
  • Michael Scrivner Congress Chief of Staff, Hon. Norman F. Lent Formerly Chief of Staff, Hon. Norman F. Lent · SCRIVNER LEON GROUP LLC · Oct 16, 2018
  • Pete Leon Congress Legislative Director, Hon. Eliot Engel Formerly Legislative Director, Hon. Eliot Engel · SCRIVNER LEON GROUP LLC · Oct 16, 2018
  • Jennifer Pharaoh Congress Special Assistant, HUD, 1998-2001; Leg. Director, Cong. Thompson, 2001-2003; Deputy Chief of Staff, Cong. Larsen 2003-2004 Formerly Special Assistant, HUD, 1998-2001; Leg. Director, Cong. Thompson, 2001-2003; Dep · NELSON MULLINS RILEY & SCARBOROUGH · Jan 18, 2018
Corporate Lobbying

NTRA Estimated quarterly lobbying spending

Revenue Breakdown

NTRA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NTRA Income Statement
NTRA Balance Sheet
NTRA Cash Flow
U.S. Patents

New NTRA patent grants

  • Patent Title: Methods for simultaneous amplification of target loci Sep. 15, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Sep. 15, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Sep. 01, 2026
  • Patent Title: Detecting disease and ploidy in chromosomal segments Aug. 25, 2026
  • Patent Title: Methods and compositions for determining ploidy Aug. 25, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Jul. 28, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Jun. 30, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Jun. 23, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Jun. 16, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Jun. 09, 2026
  • Patent Title: Primers and uses thereof Jun. 02, 2026
  • Patent Title: System and method for cleaning noisy genetic data and determining chromosome copy number Mar. 24, 2026
  • Patent Title: System and method for cleaning noisy genetic data and determining chromosome copy number Mar. 10, 2026
  • Patent Title: System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals Mar. 10, 2026
  • Patent Title: Compositions and methods for identifying nucleic acid molecules Mar. 10, 2026
  • Patent Title: System and method for cleaning noisy genetic data and determining chromosome copy number Feb. 17, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Feb. 17, 2026
  • Patent Title: Methods for enriching and sequencing nucleic acids for non-invasive cancer testing Feb. 17, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Feb. 10, 2026
  • Patent Title: Methods for simultaneous amplification of target loci Dec. 30, 2025
  • Patent Title: System and method for cleaning noisy genetic data and determining chromosome copy number Dec. 30, 2025
  • Patent Title: Methods for non-invasive prenatal ploidy calling Dec. 09, 2025
  • Patent Title: Detecting mutations and ploidy in chromosomal segments Dec. 09, 2025
  • Patent Title: Detecting mutations and ploidy in chromosomal segments Dec. 02, 2025
  • Patent Title: Method of detecting tumour recurrence Nov. 04, 2025
  • Patent Title: Methods for simultaneous amplification of target loci Sep. 09, 2025
  • Patent Title: Methods for isolating nucleic acids with size selection Aug. 26, 2025
  • Patent Title: Methods for cancer detection and monitoring Aug. 12, 2025
  • Patent Title: Methods for detecting immune cell dna and monitoring immune system May. 20, 2025
  • Patent Title: Methods for simultaneous amplification of target loci May. 20, 2025
  • Patent Title: Materials and methods for processing blood samples May. 06, 2025
  • Patent Title: Methods for preparing a biological sample obtained from an individual for use in a genetic testing assay Apr. 08, 2025
  • Patent Title: Systems and methods for detection of aneuploidy Mar. 25, 2025
  • Patent Title: Methods for characterizing copy number variation using proximity-litigation sequencing Mar. 04, 2025
  • Patent Title: Methods for detection of donor-derived cell-free dna Feb. 25, 2025
  • Patent Title: Methods for simultaneous amplification of target loci Feb. 11, 2025
  • Patent Title: System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals Jul. 04, 2017
  • Patent Title: Methods for simultaneous amplification of target loci Jun. 13, 2017
  • Patent Title: Methods for allele calling and ploidy calling May. 02, 2017
  • Patent Title: Cell free dna diagnostic testing standards Nov. 22, 2016
  • Patent Title: System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals Aug. 30, 2016
  • Patent Title: System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals Aug. 23, 2016
  • Patent Title: Methods for non-invasive prenatal ploidy calling May. 10, 2016
  • Patent Title: Methods for non-invasive prenatal ploidy calling Jan. 05, 2016
  • Patent Title: Methods for non-invasive prenatal ploidy calling Oct. 20, 2015
  • Patent Title: Methods for non-invasive prenatal ploidy calling Feb. 03, 2015
  • Patent Title: Methods for non-invasive prenatal ploidy calling Sep. 02, 2014
  • Patent Title: System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals Mar. 25, 2014
  • Patent Title: Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals Sep. 10, 2013
  • Patent Title: System and method for cleaning noisy genetic data and determining chromosome copy number Aug. 20, 2013
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to NTRA from public contracts

NTRA News

Recent insights relating to NTRA

CNBC Recommendations

Recent picks made for NTRA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NTRA

NTRA Analyst Ratings

NTRA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NTRA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NTRA stock a Buy, Sell, or Hold?

  • What is the price target for $NTRA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NTRA Top Shareholders
Shareholder
Shares Held
NTRA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NTRA stock?

  • Who owns the most shares of $NTRA stock?

  • What funds own $NTRA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NTRA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NTRA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NTRA

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

  • Address Austin, TX
  • Market Cap 56.3 billion
  • Employees 6,140
  • Industrial Classification Services-Medical Laboratories

Natera, Inc. Common Stock (NTRA) Historical Stock Prices

Natera, Inc. Common Stock (NTRA) closed at $390.79 on September 23, 2026. Over the past year its adjusted close ranged from $160.21 to $390.90. Daily prices go back to July 2, 2015, 2,823 trading days in all.

  • 1 month+19.25%
  • 3 months+50.32%
  • Year to date+70.58%
  • 1 year+126.11%
  • 3 years+752.88%
  • 5 years+230.84%
  • Max+1,618.51%
See every congressional and insider trade on the NTRA price chart

Quiver Premium charts NTRA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 386.94 394.86 384.96 390.79 390.79 1,690,564
Sep 22, 2026 368.26 391.93 365.20 390.90 390.90 1,552,969
Sep 21, 2026 371.92 373.07 363.96 370.64 370.64 1,981,768
Sep 18, 2026 365.78 369.69 358.90 369.39 369.39 3,718,175
Sep 17, 2026 350.50 366.70 348.26 366.31 366.31 2,561,081
Sep 16, 2026 350.18 357.14 343.27 345.34 345.34 1,432,954
Sep 15, 2026 340.34 351.78 338.82 350.78 350.78 1,775,774
Sep 14, 2026 327.91 343.00 327.15 341.79 341.79 1,043,161
Sep 11, 2026 330.18 330.18 324.45 328.93 328.93 798,060
Sep 10, 2026 324.92 331.19 320.65 326.14 326.14 1,070,696
Sep 9, 2026 324.14 331.88 321.19 330.31 330.31 707,347
Sep 8, 2026 326.29 331.40 321.21 324.14 324.14 1,030,273
Sep 4, 2026 323.92 329.05 323.42 328.18 328.18 968,221
Sep 3, 2026 325.65 332.00 320.01 327.67 327.67 711,938
Sep 2, 2026 318.53 330.92 318.00 325.17 325.17 1,033,232
Sep 1, 2026 320.99 325.00 318.36 320.76 320.76 1,208,845
Aug 31, 2026 320.95 325.65 316.00 321.96 321.96 1,326,118
Aug 28, 2026 335.28 339.30 325.66 326.26 326.26 833,869
Aug 27, 2026 337.46 343.18 334.45 338.70 338.70 731,371
Aug 26, 2026 333.29 340.96 333.29 338.45 338.45 1,094,667
Aug 25, 2026 330.31 337.12 325.98 336.71 336.71 1,733,153
Aug 24, 2026 328.40 331.91 321.59 327.72 327.72 1,219,524
Aug 21, 2026 325.00 332.98 320.41 332.03 332.03 1,215,079
Aug 20, 2026 321.05 333.56 320.00 324.84 324.84 1,738,495
Aug 19, 2026 321.01 325.83 313.46 325.07 325.07 1,792,088
Aug 18, 2026 311.63 318.57 310.38 311.69 311.69 1,132,547
Aug 17, 2026 310.49 318.61 308.40 314.18 314.18 1,271,463
Aug 14, 2026 308.01 311.99 305.00 309.93 309.93 1,273,757
Aug 13, 2026 317.68 319.91 307.99 310.78 310.78 1,522,100
Aug 12, 2026 313.47 321.72 312.00 315.96 315.96 1,579,749
Aug 11, 2026 317.78 319.98 311.73 312.72 312.72 953,404
Aug 10, 2026 321.53 326.03 310.95 318.35 318.35 2,154,605
Aug 7, 2026 320.90 323.01 306.38 322.10 322.10 3,386,988
Aug 6, 2026 267.71 272.37 263.55 265.38 265.38 1,590,333
Aug 5, 2026 275.19 279.97 271.52 274.62 274.62 1,128,824
Aug 4, 2026 270.36 276.97 265.24 275.19 275.19 1,923,115
Aug 3, 2026 265.10 272.54 259.80 270.36 270.36 1,156,393
Jul 31, 2026 275.00 275.12 262.29 267.76 267.76 1,331,433
Jul 30, 2026 252.39 271.25 252.39 269.66 269.66 1,184,137
Jul 29, 2026 251.34 258.03 248.03 253.82 253.82 925,272
Jul 28, 2026 256.46 257.44 248.58 252.22 252.22 1,024,690
Jul 27, 2026 263.83 267.27 257.00 258.03 258.03 977,943
Jul 24, 2026 264.69 266.87 260.27 261.99 261.99 699,587
Jul 23, 2026 264.22 273.00 261.59 264.69 264.69 598,334
Jul 22, 2026 263.38 266.00 257.84 264.22 264.22 807,067
Jul 21, 2026 262.09 268.71 255.66 267.18 267.18 994,675
Jul 20, 2026 268.81 271.64 262.01 262.63 262.63 833,725
Jul 17, 2026 265.40 272.31 262.00 271.39 271.39 1,014,525
Jul 16, 2026 279.69 282.00 268.16 269.83 269.83 948,974
Jul 15, 2026 274.82 278.71 271.14 277.37 277.37 867,755
Jul 14, 2026 276.73 278.80 271.23 272.66 272.66 954,842
Jul 13, 2026 266.88 273.33 261.63 272.89 272.89 1,528,001
Jul 10, 2026 281.85 283.87 268.97 269.95 269.95 969,803
Jul 9, 2026 273.14 283.76 273.00 281.85 281.85 1,958,307
Jul 8, 2026 276.59 279.83 269.66 274.39 274.39 1,398,594
Jul 7, 2026 284.51 287.63 278.07 281.27 281.27 1,759,681
Jul 6, 2026 277.50 288.04 276.40 283.80 283.80 1,358,559
Jul 2, 2026 278.47 279.63 271.64 279.32 279.32 1,274,247
Jul 1, 2026 273.00 279.42 266.33 276.27 276.27 1,862,134
Jun 30, 2026 271.45 275.24 265.39 271.45 271.45 1,371,653
Jun 29, 2026 265.00 274.86 263.00 272.31 272.31 1,784,305
Jun 26, 2026 262.42 270.43 257.07 261.91 261.91 3,411,940
Jun 25, 2026 258.93 271.47 258.50 260.74 260.74 2,466,865
Jun 24, 2026 243.00 264.65 239.00 259.97 259.97 2,941,675
Jun 23, 2026 225.71 240.72 224.35 234.76 234.76 2,063,403
Jun 22, 2026 231.52 234.13 219.50 228.80 228.80 1,577,833
Jun 18, 2026 232.64 237.15 227.93 231.41 231.41 2,630,815
Jun 17, 2026 219.18 231.89 217.72 226.44 226.44 1,777,619
Jun 16, 2026 216.78 223.93 214.77 220.11 220.11 1,379,089
Jun 15, 2026 213.64 219.44 209.57 216.97 216.97 1,017,277
Jun 12, 2026 223.71 223.71 208.79 212.07 212.07 811,714
Jun 11, 2026 216.68 221.62 213.07 219.23 219.23 736,171
Jun 10, 2026 221.66 224.70 215.51 216.50 216.50 1,026,263
Jun 9, 2026 216.60 222.98 211.25 222.82 222.82 1,210,898
Jun 8, 2026 215.86 220.09 212.03 213.47 213.47 1,115,253
Jun 5, 2026 218.19 222.13 214.82 215.31 215.31 849,450
Jun 4, 2026 213.95 227.90 212.17 222.10 222.10 1,266,680
Jun 3, 2026 209.47 213.26 204.16 211.85 211.85 1,463,511
Jun 2, 2026 214.80 216.97 210.79 212.73 212.73 1,175,048
Jun 1, 2026 220.83 225.10 216.60 218.81 218.81 1,334,256
May 29, 2026 214.97 225.70 211.40 223.37 223.37 2,691,331
May 28, 2026 202.65 214.16 200.17 213.94 213.94 1,863,233
May 27, 2026 200.52 204.64 196.44 203.11 203.11 1,273,627
May 26, 2026 205.47 209.00 197.63 200.91 200.91 1,466,529
May 22, 2026 204.37 210.67 202.25 203.19 203.19 1,036,809
May 21, 2026 204.75 210.00 198.97 203.69 203.69 1,493,380
May 20, 2026 199.75 205.36 197.16 204.92 204.92 1,513,927
May 19, 2026 193.45 198.11 190.05 196.04 196.04 1,273,923
May 18, 2026 190.00 197.53 188.50 192.54 192.54 2,145,437
May 15, 2026 197.61 198.65 184.81 186.36 186.36 2,239,958
May 14, 2026 195.51 200.51 195.08 196.91 196.91 1,382,251
May 13, 2026 204.08 204.08 194.03 195.32 195.32 1,664,304
May 12, 2026 199.46 206.00 198.01 204.21 204.21 1,566,969
May 11, 2026 194.12 202.42 190.57 199.14 199.14 2,041,865
May 8, 2026 210.00 217.65 192.52 194.24 194.24 3,925,677
May 7, 2026 215.50 221.56 209.89 219.82 219.82 2,765,926
May 6, 2026 208.54 218.09 206.42 215.09 215.09 2,136,392
May 5, 2026 213.00 213.84 205.00 206.77 206.77 1,065,764
May 4, 2026 206.87 212.00 204.52 211.56 211.56 1,291,590
May 1, 2026 205.29 208.66 200.07 207.28 207.28 946,722
Apr 30, 2026 196.74 209.91 196.69 206.16 206.16 1,772,736
Apr 29, 2026 197.52 199.81 189.53 194.75 194.75 963,979
Apr 28, 2026 200.96 202.99 195.97 200.17 200.17 1,664,748
Apr 27, 2026 202.60 207.79 201.94 204.39 204.39 1,064,401
Apr 24, 2026 201.14 206.44 198.64 203.75 203.75 1,000,439
Apr 23, 2026 204.89 204.93 192.79 201.14 201.14 1,166,354
Apr 22, 2026 207.41 209.33 203.47 207.78 207.78 1,001,648
Apr 21, 2026 208.00 212.77 205.21 205.42 205.42 770,039
Apr 20, 2026 206.32 210.87 206.13 207.74 207.74 824,808
Apr 17, 2026 200.14 209.28 198.28 208.40 208.40 1,427,090
Apr 16, 2026 205.01 205.66 194.29 196.11 196.11 1,849,023
Apr 15, 2026 217.62 219.47 206.26 207.19 207.19 1,381,774
Apr 14, 2026 207.52 215.00 206.36 214.64 214.64 1,734,420
Apr 13, 2026 193.73 202.81 193.73 201.90 201.90 1,203,867
Apr 10, 2026 202.92 205.58 184.00 193.03 193.03 2,871,768
Apr 9, 2026 209.35 209.39 199.54 203.00 203.00 1,490,869
Apr 8, 2026 215.96 220.00 209.86 210.83 210.83 1,094,586
Apr 7, 2026 205.28 209.75 203.17 209.27 209.27 906,452
Apr 6, 2026 206.34 208.32 203.14 204.87 204.87 808,942
Apr 2, 2026 198.19 210.99 198.02 207.98 207.98 1,280,030
Apr 1, 2026 201.00 205.98 199.66 203.21 203.21 1,294,671
Mar 31, 2026 190.34 200.56 190.29 199.99 199.99 1,419,747
Mar 30, 2026 184.03 187.00 181.48 186.84 186.84 995,198
Mar 27, 2026 195.69 195.99 181.00 182.65 182.65 1,063,248
Mar 26, 2026 195.36 198.52 194.56 196.15 196.15 643,564
Mar 25, 2026 196.40 202.88 195.78 197.37 197.37 666,717
Mar 24, 2026 198.77 198.77 191.50 194.52 194.52 787,282
Mar 23, 2026 197.10 201.87 196.74 200.09 200.09 853,869
Mar 20, 2026 200.63 201.29 194.02 195.28 195.28 2,362,767
Mar 19, 2026 196.63 204.34 196.00 202.73 202.73 1,220,280
Mar 18, 2026 197.54 200.43 195.29 197.79 197.79 1,450,754
Mar 17, 2026 199.53 203.29 197.75 198.38 198.38 1,143,189
Mar 16, 2026 191.44 198.18 190.66 197.68 197.68 1,574,981
Mar 13, 2026 191.38 192.36 187.01 187.85 187.85 1,261,748
Mar 12, 2026 193.75 195.40 186.07 190.31 190.31 1,758,706
Mar 11, 2026 196.36 201.27 194.55 196.61 196.61 1,404,791
Mar 10, 2026 205.98 207.08 198.45 198.95 198.95 903,174
Mar 9, 2026 194.19 205.62 194.19 205.22 205.22 1,422,703
Mar 6, 2026 193.27 198.34 193.27 198.13 198.13 1,226,265
Mar 5, 2026 201.01 203.28 193.85 197.14 197.14 1,465,404
Mar 4, 2026 207.17 208.60 201.85 203.03 203.03 859,313
Mar 3, 2026 195.67 210.51 192.59 207.04 207.04 1,543,055
Mar 2, 2026 200.17 203.91 196.22 200.17 200.17 1,486,762
Feb 27, 2026 211.02 212.99 196.22 208.04 208.04 2,761,910
Feb 26, 2026 212.67 216.64 211.20 216.10 216.10 1,202,728
Feb 25, 2026 211.65 214.39 209.02 211.83 211.83 1,014,172
Feb 24, 2026 208.40 212.48 207.22 209.53 209.53 693,447
Feb 23, 2026 211.74 212.88 207.01 209.35 209.35 776,555
Feb 20, 2026 216.36 218.25 208.57 212.12 212.12 1,180,399
Feb 19, 2026 216.73 218.50 213.20 216.36 216.36 744,830
Feb 18, 2026 211.76 220.65 210.57 215.53 215.53 1,002,269
Feb 17, 2026 206.06 211.51 204.24 211.25 211.25 791,216
Feb 13, 2026 208.83 213.30 204.04 206.23 206.23 790,455
Feb 12, 2026 211.33 213.96 204.06 207.84 207.84 931,356
Feb 11, 2026 212.59 212.77 203.86 212.46 212.46 898,399
Feb 10, 2026 210.15 214.36 209.94 211.65 211.65 1,054,507
Feb 9, 2026 207.31 213.49 207.29 210.58 210.58 1,183,789
Feb 6, 2026 199.73 203.68 194.02 203.04 203.04 1,563,978
Feb 5, 2026 204.53 209.76 195.46 197.08 197.08 1,783,130
Feb 4, 2026 226.36 226.75 204.86 205.61 205.61 2,452,467
Feb 3, 2026 232.44 236.58 224.21 227.68 227.68 937,159
Feb 2, 2026 228.50 234.22 226.24 231.10 231.10 1,250,361
Jan 30, 2026 231.47 235.62 229.30 231.14 231.14 666,012
Jan 29, 2026 234.92 235.01 229.14 231.48 231.48 947,131
Jan 28, 2026 240.96 240.99 235.61 235.93 235.93 871,617
Jan 27, 2026 240.46 244.33 238.87 240.34 240.34 578,787
Jan 26, 2026 241.15 246.26 239.00 241.39 241.39 656,073
Jan 23, 2026 243.63 249.26 240.57 241.58 241.58 961,083
Jan 22, 2026 243.12 250.00 242.21 242.91 242.91 971,270
Jan 21, 2026 235.00 243.69 234.04 242.78 242.78 1,416,301
Jan 20, 2026 228.08 235.46 226.66 234.85 234.85 1,473,902
Jan 16, 2026 239.35 241.00 230.13 231.25 231.25 1,470,471
Jan 15, 2026 240.24 243.03 234.51 240.34 240.34 1,013,880
Jan 14, 2026 235.86 239.38 233.45 239.19 239.19 904,079
Jan 13, 2026 236.84 239.43 230.96 237.89 237.89 1,144,017
Jan 12, 2026 236.00 243.47 226.12 235.45 235.45 1,738,918
Jan 9, 2026 241.84 241.90 232.36 234.31 234.31 1,016,199
Jan 8, 2026 252.48 256.00 232.29 239.56 239.56 1,977,730
Jan 7, 2026 253.08 256.36 250.26 254.40 254.40 1,199,524
Jan 6, 2026 237.50 249.15 237.42 248.74 248.74 1,550,802
Jan 5, 2026 229.88 237.50 227.69 237.42 237.42 1,088,619
Jan 2, 2026 228.95 230.06 225.82 228.84 228.84 827,085
Dec 31, 2025 229.98 231.91 228.81 229.09 229.09 621,606
Dec 30, 2025 230.63 232.60 227.89 229.98 229.98 660,388
Dec 29, 2025 232.65 233.66 230.09 231.30 231.30 491,769
Dec 26, 2025 233.45 236.33 233.36 233.74 233.74 410,921
Dec 24, 2025 234.68 236.37 232.69 235.54 235.54 468,119
Dec 23, 2025 234.71 236.99 232.05 235.40 235.40 1,003,865
Dec 22, 2025 233.91 237.04 231.07 235.57 235.57 1,462,932
Dec 19, 2025 227.05 232.39 224.74 231.96 231.96 2,218,246
Dec 18, 2025 225.49 228.71 223.98 224.74 224.74 1,288,937
Dec 17, 2025 227.79 228.38 221.84 225.49 225.49 1,870,866
Dec 16, 2025 227.81 229.22 225.80 227.40 227.40 898,294
Dec 15, 2025 229.29 232.76 227.00 228.40 228.40 1,141,698
Dec 12, 2025 231.50 232.23 225.58 231.95 231.95 1,363,037
Dec 11, 2025 230.01 234.82 227.44 231.05 231.05 1,116,809
Dec 10, 2025 235.58 239.22 231.68 233.13 233.13 1,299,866
Dec 9, 2025 239.50 241.45 234.06 235.53 235.53 1,082,252
Dec 8, 2025 245.33 246.90 238.06 239.14 239.14 1,403,678
Dec 5, 2025 242.22 245.59 239.00 244.55 244.55 1,369,773
Dec 4, 2025 239.11 243.73 237.86 242.06 242.06 1,234,900
Dec 3, 2025 237.80 239.18 234.63 238.21 238.21 1,576,305
Dec 2, 2025 236.95 238.73 233.83 236.64 236.64 1,063,181
Dec 1, 2025 239.64 240.18 233.67 234.25 234.25 824,163
Nov 28, 2025 236.99 239.76 235.77 238.81 238.81 500,604
Nov 26, 2025 238.39 241.28 236.53 237.12 237.12 1,320,799
Nov 25, 2025 240.40 240.40 233.21 236.49 236.49 1,863,164
Nov 24, 2025 230.63 239.40 227.71 238.58 238.58 2,404,011
Nov 21, 2025 225.00 235.89 223.60 230.63 230.63 2,871,365
Nov 20, 2025 220.00 229.95 220.00 225.55 225.55 3,445,057
Nov 19, 2025 214.44 220.53 212.33 218.35 218.35 2,143,948
Nov 18, 2025 204.73 215.81 204.35 213.65 213.65 2,172,050
Nov 17, 2025 204.28 208.54 203.00 206.04 206.04 1,076,259
Nov 14, 2025 196.27 205.80 195.14 204.28 204.28 1,289,082
Nov 13, 2025 206.46 209.00 200.34 200.67 200.67 1,490,297
Nov 12, 2025 206.72 212.21 206.72 209.50 209.50 1,538,097
Nov 11, 2025 207.44 210.09 205.68 206.72 206.72 1,230,754
Nov 10, 2025 201.00 210.90 199.73 206.63 206.63 1,452,760
Nov 7, 2025 186.28 201.20 182.20 199.57 199.57 2,707,182
Nov 6, 2025 198.69 201.08 195.87 198.48 198.48 1,929,147
Nov 5, 2025 196.63 202.00 193.18 199.92 199.92 1,230,634
Nov 4, 2025 196.45 203.22 195.62 196.45 196.45 1,849,001
Nov 3, 2025 198.71 200.76 194.07 198.23 198.23 1,636,930
Oct 31, 2025 193.41 199.21 192.29 198.93 198.93 1,921,302
Oct 30, 2025 194.30 198.56 190.56 193.22 193.22 1,044,742
Oct 29, 2025 188.06 195.12 188.06 192.81 192.81 893,286
Oct 28, 2025 191.97 192.69 189.01 189.57 189.57 946,599
Oct 27, 2025 194.72 195.44 189.38 192.22 192.22 1,108,907
Oct 24, 2025 196.77 198.99 191.75 192.51 192.51 1,086,142
Oct 23, 2025 187.16 195.07 187.16 195.00 195.00 936,886
Oct 22, 2025 186.68 189.02 183.88 188.02 188.02 1,333,768
Oct 21, 2025 187.95 190.20 185.65 186.88 186.88 782,635
Oct 20, 2025 184.72 196.63 183.46 188.60 188.60 1,737,329
Oct 17, 2025 179.09 182.42 178.01 181.69 181.69 998,242
Oct 16, 2025 179.58 187.34 179.15 180.54 180.54 1,189,529
Oct 15, 2025 173.24 181.88 172.82 179.42 179.42 1,278,424
Oct 14, 2025 173.00 176.36 170.81 172.81 172.81 882,028
Oct 13, 2025 170.00 174.57 169.08 174.17 174.17 1,202,742
Oct 10, 2025 173.17 173.78 167.99 169.27 169.27 971,509
Oct 9, 2025 171.46 174.75 171.02 173.06 173.06 859,816
Oct 8, 2025 170.58 173.16 169.16 172.09 172.09 946,516
Oct 7, 2025 170.46 173.62 167.33 168.53 168.53 1,052,904
Oct 6, 2025 167.36 172.68 167.22 170.38 170.38 1,424,689
Oct 3, 2025 161.54 167.91 160.59 167.35 167.35 1,145,532
Oct 2, 2025 161.91 161.91 157.43 160.21 160.21 1,042,396
Oct 1, 2025 160.11 163.40 157.79 161.61 161.61 1,583,924
Sep 30, 2025 162.44 164.64 159.95 160.97 160.97 1,214,039
Sep 29, 2025 163.22 164.88 162.39 163.09 163.09 1,087,934
Sep 26, 2025 163.58 164.69 160.02 162.97 162.97 1,220,311
Sep 25, 2025 161.31 166.35 160.07 163.66 163.66 1,481,164
Sep 24, 2025 173.15 173.15 163.65 163.91 163.91 1,100,540
Sep 23, 2025 179.19 179.65 171.86 172.83 172.83 1,752,865

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Natera, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at NTRA, per a recent SEC DEF 14A filing. We estimate that the median employee at Natera, Inc. is paid $136,511.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation